A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital

Priyanka Pahari; Debanjali Chakrabarti; Ritwik Ganguli; Julie Bhattacharya

doi:10.5455/NJPPP.2024.v14.i11.24

2024, Vol: 14, Issue: 12

14 / 12Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form

« Previous Article

Original Research
Online Published: 27 Dec 2024

Natl J Physiol Pharm Pharmacol. 2024; 14(11): 2478-2483

doi: 10.5455/NJPPP.2024.v14.i11.24

A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital

Priyanka Pahari, Debanjali Chakrabarti, Ritwik Ganguli, Julie Bhattacharya.

Abstract
Background:
Depression and osteoporosis are severe public health problems. There are conflicting findings regarding the influence of depression on bone metabolism. Depression has been linked to an increased risk of osteoporosis, but the underlying mechanisms remain unclear. Depression has been implicated as a possible risk factor for low bone mineral density (BMD). However, there is still no solid evidence that could connect these two different illnesses. Many studies in this area are observational, which means they can show associations but not prove causation.

Aim:
The aim of the presented study was to compare bone turnover markers between osteoporosis patients associated with depression and healthy controls.

Methods:
We determined a concentration of serum cortisol, creatinine, TSH and 1,25(OH)2D3 in 60 osteoporotic patients, aged 46.9 ± 17 years, associated with depression, as well as in 60 healthy subjects. Depressive status was determined with the Hamilton Depression Scale (HAMD).

Results:
In osteoporotic patients with depression, we observed significantly lower bone mineral density concentrations (p < 0.05) and higher concentration of cortisol (result on the border of significance; p = 0.08). The level of TSH and 1,25(OH)2D3 did not differ significantly between the examined groups. We observed a negative correlation of the eGFR as compare with creatinine score in all osteoporotic patients with depression. We found that patients with depression had significantly higher levels of bone resorption markers (cortisol) and lower levels of bone formation markers (vitamin D) compared to healthy controls.

Conclusion:
Our results indicate that depression is related to disturbances in bone metabolism, especially in women, suggesting its role in context of osteoporosis development. Our findings suggest that bone markers may be useful in identifying individuals at risk of depression-related osteoporosis.

Key words: Depression, Bone markers, Cortisol, Vitamin D, eGFR

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Priyanka Pahari Articles by Debanjali Chakrabarti Articles by Ritwik Ganguli Articles by Julie Bhattacharya
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Pahari P, Chakrabarti D, Ganguli R, Bhattacharya J. A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2024; 14(11): 2478-2483. doi:10.5455/NJPPP.2024.v14.i11.24

Web Style

Pahari P, Chakrabarti D, Ganguli R, Bhattacharya J. A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital. https://www.njppp.com/?mno=211807 [Access: January 17, 2025]. doi:10.5455/NJPPP.2024.v14.i11.24

AMA (American Medical Association) Style

Pahari P, Chakrabarti D, Ganguli R, Bhattacharya J. A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2024; 14(11): 2478-2483. doi:10.5455/NJPPP.2024.v14.i11.24

Vancouver/ICMJE Style

Pahari P, Chakrabarti D, Ganguli R, Bhattacharya J. A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. (2024), [cited January 17, 2025]; 14(11): 2478-2483. doi:10.5455/NJPPP.2024.v14.i11.24

Harvard Style

Pahari, P., Chakrabarti, . D., Ganguli, . R. & Bhattacharya, . J. (2024) A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital. Natl J Physiol Pharm Pharmacol, 14 (11), 2478-2483. doi:10.5455/NJPPP.2024.v14.i11.24

Turabian Style

Pahari, Priyanka, Debanjali Chakrabarti, Ritwik Ganguli, and Julie Bhattacharya. 2024. A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 14 (11), 2478-2483. doi:10.5455/NJPPP.2024.v14.i11.24

Chicago Style

Pahari, Priyanka, Debanjali Chakrabarti, Ritwik Ganguli, and Julie Bhattacharya. "A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 2478-2483. doi:10.5455/NJPPP.2024.v14.i11.24

MLA (The Modern Language Association) Style

Pahari, Priyanka, Debanjali Chakrabarti, Ritwik Ganguli, and Julie Bhattacharya. "A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 14.11 (2024), 2478-2483. Print. doi:10.5455/NJPPP.2024.v14.i11.24

APA (American Psychological Association) Style

Pahari, P., Chakrabarti, . D., Ganguli, . R. & Bhattacharya, . J. (2024) A prospective study of bone biomarker for the clinical assessment of osteoporosis associated with depression in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 14 (11), 2478-2483. doi:10.5455/NJPPP.2024.v14.i11.24

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Digital Archiving & Preservation Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article